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Work in large part on Leishmania major in the 1980s identiﬁed two distinct apparently
counter-regulatory CD4+ T cell populations, T helper (h)1 and Th2, that controlled resis-
tance/susceptibility to infection respectively. However, the generation of IL-4−/− mice in
the 1990s questioned the paramount role of thisTh2 archetypal cytokine in the non-healing
response to Leishmania infection. The more recent characterization of CD4+ T cell regula-
tory populations and further effector CD4+ T helper populations, Th17, Th9, and T follicular
(f)h cells as well as the acknowledged plasticity in T helper cell function has further added
to the complexity of host pathogen interactions.These interactions are complicated by the
multiplicity of cells that respond to CD4+ T cell subset signatory cytokines, as well as the
diversity of Leishmania species that are often subject to signiﬁcantly different immune-
regulatory controls. In this article we review current knowledge with regard to the role of
CD4+ T cells and their products during Leishmania infection. In particular we update on
our studies using conditional IL-4Rα gene-deﬁcient mice that have allowed dissection of
the cell interplay dictating the disease outcomes of the major Leishmania species infecting
humans.
Keywords: Leishmania, T helper 1, T helper 2, T regulatory cells, T helper 17, T follicular helper cells, interleukin-4,
interferon-gamma
INTRODUCTION
The identiﬁcation, based on their different cytokine proﬁles, of at
least two distinct populations of CD4+ T helper cells was made
by Mosmann et al. (1986). Further studies, in large part utiliz-
ing the murine model of Leishmania major infection, gave rise
to the Th1/Th2 paradigm of resistance/susceptibility to intracel-
lular infection whereby an IL-4 driven Th2 response counter-
regulated a protective Th1 response and resulted in non-healing
disease (Heinzel et al., 1989). Indeed Leishmania species have long
been considered ideal models to study the mechanisms underling
persistent intracellular infections. In the ﬁrst instance protective
immunity against all species is by general consensus recognized
as being Th1 dependent. However, as the causative agents of both
Old World and New World cutaneous leishmaniasis as well as vis-
ceral leishmaniasis diverged in evolutionary terms 40–80million
years ago (reviewed McMahon-Pratt and Alexander, 2004) they
have had signiﬁcant time to develop different mechanisms to sur-
vive within the mammalian host. As a consequence these various
species have provided excellent tools to dissect different pathways
of subverting the development of protective Th1 responses. Sub-
sequently, studies using cytokine deﬁcient mice as well as different
species and lineages of Leishmania have certainly questioned the
simplicity, if not as yet totally undermined the basic premise, of
the Th1/Th2 paradigm of resistance/susceptibility to intracellular
infection. Part of the re-evaluation of the “Th1/Th2” paradigm
results from the identiﬁcation of further CD4+ T cell populations
that can signiﬁcantly inﬂuence disease outcomes (Figure 1). Such
populations include CD4+ T cell regulatory populations, as well
as further CD4+ T helper populations Th17, Th9, and T follicu-
lar helper (fh) cells (Bettelli et al., 2007; Korn et al., 2009; Jäeger
and Kuchroo, 2010; Crotty, 2011; Peterson, 2012). There is also
increasing evidence of plasticity in function of different CD4+ T
cell populations that while adding to the perceived complexity of
host pathogen interactions may also clarify previous apparently
anomalous reports.
The traditional counter-regulatory roles for Th1 and Th2 cells
and their signatory cytokines IFN-γ and IL-4 are also subject
to signiﬁcant debate as new information has accumulated. For
example, the archetypal Th2 cytokines IL-4 and IL-13 need not
necessarily counter-regulate a type-1 response as initially pro-
posed, but can also in certain disease models or experimental
conditions drive, facilitate, or promote a Th1 response (Alexan-
der et al., 2000; Biedermann et al., 2001; Stager et al., 2003a,b;
Murray et al., 2006; McFarlane et al., 2011). Furthermore Th2
responses can be induced independently of the signatory cytokine
IL-4 (Mohrs et al., 2000). IL-4/IL-13 mediated Th1 activities
include inducing macrophage and dendritic cell IL-12 produc-
tion (Hochrein et al., 2000; McDonald et al., 2004), enhancing
IFN-γ production (Noble and Kemeny, 1995), or synergizing with
IFN-γ for enhanced anti-microbial activity (Bogdan et al., 1991;
Lean et al., 2003). These studies emphasize the pleiotropic activi-
ties of IL-4 and IL-13. Numerous cell types of both the innate and
adaptive immune responses not only produce these cytokines but
also express their receptors. Thus, many apparently contradictory
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FIGURE 1 |The mechanisms that influence the expansion of different
CD4+ T cell populations as part of the adaptive immune response
following Leishmania major infection, and their role in determining the
outcome of disease. Early IL-4 (IL-13) instructs DCs to produce IL-12 that
together with antigen presentation drives the expansion of Th1 cells. IFN-γ
production fromTh1 cells induces classical macrophage activation, nitric oxide
production, and parasite killing. Latent infection, but also in more virulent
models, persistent infection is maintained by type-1 regulatory cells
producing both IFN-γ and IL-10, and natural T regulatory cells producing IL-10.
In the absence of early IL-4, B regulatory cells producing IL-10 instruct the
inhibition of DC IL-12 production allowing the expansion of non-Th1
populations. Under the inﬂuence of TGF-β, expansion of Th17 cells causes
neutrophil inﬂux into lesions which is often associated with increased
pathology. Expansion of Th2, Th9, andTfh2 cells is further facilitated under the
inﬂuence of IL-4 from Vβ4Vα8 CD4+ T cells responding to the parasite LACK
antigen. Type-2 cytokines fromTh2/Th9 populations induce alternative
macrophage activation, increased arginase expression, and parasite
expansion. Tfh2 cells induce B cell IgG1 production and IgG1 opsonized
parasites via macrophage FcγR uptake stimulates host cell IL-10 release
which together with the inﬂuence of cytokines from the other non-Th1 CD4+
T cell populations promotes progressive disease. Overall depending on the
virulence of the L. major parasite strains and the animal model examined
these various CD4+ T cell populations interact to create a dynamic disease
spectrum. Studies on L. donovani infections would suggest that type-2
responses are not disease promoting for visceral leishmaniasis while those
with L. mexicana would suggest a signiﬁcant role.
reports on IL-4/IL-13 inﬂuences during infections with different
species or strains of Leishmania may result in large part from the
hierarchy of importance of different target cell/IL-4 and or IL-
13 interactions within the overall global network of IL-4/IL-13
activities in an individual host model system.
In this review we shall outline and discuss, using different
species of Leishmania, our current knowledge of how different
CD4+ T cells and their cytokine products operate to inﬂuence the
disease process. In particular we shall update on our studies using
tissue speciﬁc IL-4Rα−/− mice what information has been dis-
cerned with regard to the cell targets for IL-4/IL-13 that promote
non-healing or healing disease. Table 1 lists the cell-type speciﬁc
IL-4Rα deﬁcient mice that have been created to date and indicates
which have so far been tested in Leishmania infection models.
T HELPER 1 CD4+ CELLS AND THEIR ROLE IN LEISHMANIASIS
It is now well established that a protective immune response
against both cutaneous leishmaniasis, caused by L. major, L. mexi-
cana, or L. amazonensis, as well as visceral leishmaniasis caused by
L. donovani or L. infantum, is dependent on the development of
Th1 immunity (reviewed McMahon-Pratt and Alexander, 2004).
The general consensus is that IL-12 from antigen-presenting cells
(APCs), macrophages, and dendritic cells, drives the differenti-
ation and proliferation of Th1 cells via Stat-4 induced IFN-γ
expression which in turn activates Stat-1 to induce T-bet which
is recognized as the master regulator of Th1 cells. Stat-1 activation
is also essential for the upregulation of CXCR3 and the hom-
ing of CD4+ Th1 cells to sites of infection and draining lymph
nodes (Barbi et al., 2009). These responses depending on the
host/parasite model can be augmented by cytokines such as IL-1β
(Von Stebut et al., 2003; Xin et al., 2007), IL-18 (Wei et al., 2004),
IL-6 (Stager et al., 2006), and IL-27 (Artis et al., 2004). MHC Class
II antigen presentation and cytokine inﬂuences alone are not suf-
ﬁcient to stimulate Th1 responses and ligation of co-stimulatory
molecules, B7-1/B7-2, and CD40 on the APC with CD28 and
CD40L on the T cell respectively have also been described as
prerequisites (Bogdan et al., 1996). Ligation of CD40/CD40L
enhances APC IL-12 production (Heinzel et al., 1998) although
Frontiers in Immunology | Microbial Immunology April 2012 | Volume 3 | Article 80 | 2
Alexander and Brombacher CD4+ T cells and Leishmania
Table 1 | Global and conditional IL-4Rα gene-deficient mouse models currently available or being characterized.
Deficient mouse strain IL-4Rα cell specificity Reference
GLOBAL DEFICIENCY
IL-4Rα−/− All cells1 Mohrs et al. (1999)
IL-4Rαlox/lox “Floxed” IL-4Rα Herbert et al. (2004)
CELL-TYPE DEFICIENCY
LysMcreTgIL-4Rα−/lox Macrophages and neutrophils2 Herbert et al. (2004)
SMMHCcreTgIL-4Rα−/lox Smooth muscle cells Horsnell et al. (2007)
LckcreTgIL-4Rα−/lox CD4+ T lymphocytes3 Radwanska et al. (2007)
iLckcreTgIL-4Rα−/lox All T lymphocytes4 Dewals et al. (2009)
CD4creTgIL-4Rα−/lox α/β+ TCRT lymphocytes Unpublished
MB1creTgIL-4Rα−/lox B lymphocytes5 Hoving et al. (2012)
CD11ccreTgIL-4Rα−/lox Dendritic cells6 In characterization
LysMcreTgLckcreIL-4Rα−/lox Macrophages/neutrophils/CD4+/T cells In characterization
INDUCIBLE AND CELL-TYPE DEFICIENCY OR RECONSTITUTION
TetOIL4RαTg All cells Unpublished
GT(ROSA)26Sortm1(tTA)Roos/JLysMcre TetOIL4RαTgIL-4Rα−/− Macrophage/neutrophil reconstitution and inducible deﬁciency In characterization
LcKtTATg TetOIL4RαTgIL-4Rα−/− T cell IL-4Rα reconstitution and inducible deﬁciency In characterization
ERcreTgIL-4Rα−/lox Inducible global IL-4Rα deﬁciency In characterization
Global IL-4Rα−/− mice1 have revealed a disease exacerbating role for IL-4Rα signaling during primary infection with L. major (Mohrs et al., 1999) and L. mexicana
(Alexander et al., 2002) but a protective role during L. donovani infection (Stager et al., 2003a). Furthermore vaccination against L. donovani is ineffective in the
absence of IL-4Rα (Stager et al., 2003b). While macrophage/neutrophil speciﬁc IL-4Rα−/− mice2 have revealed a signiﬁcant role for alternative macrophage activation
during the course of L. major infection (Hoelscher et al., 2006) no such role was identiﬁed following L. mexicana (Bryson et al., 2011) or L. donovani (McFarlane et al.,
2011) infection. CD4+ T cell3 and Pan T cell4 speciﬁc IL-4Ra−/− mice have identiﬁed IL-4Rα signaling through CD4+ T cells as mediating progressive disease following
L. major (Radwanska et al., 2007) or L. mexicana (Bryson et al., 2011) infection. Interestingly while CD4+ T cell speciﬁc IL-4Rα−/− mice of either sex healed following
L. major infection only female mice healed following infection with L. mexicana. Studies are currently ongoing or nearing completion to determine the role of IL-4Rα
signaling speciﬁcally via B cells5 or DCs6 in these various disease models.
CD40 ligation may not be necessary to promote healing following
low level infections (Padigel and Farrell, 2003) and under these
circumstances TRANCE-RANK co-stimulation promotes IL-12
production (Padigel et al., 2003b). IFN-γ from Th1 cells, medi-
ates macrophage activation, nitric oxide production, and parasite
killing (reviewed Cunningham, 2002). Macrophage leishmanici-
dal activity induced by IFN-γmay be enhanced by other cytokines
such asTNF-α andmigration inhibition factor (MIF;Mannheimer
et al., 1996; Jüttner et al., 1998; Xu et al., 2003) and type-1 interfer-
ons (Diefenbach et al., 1998) as well as CD40/CD40L interactions
(Campbell et al., 1996; Kamanaka et al., 1996; Soong et al., 1996;
Heinzel et al., 1998). The exquisite susceptibility of BALB/c mice
has been attributed to intrinsic defects associated with their Th1
cells such as an inability to upregulate CXCR3 and home to lesions
(Barbi et al., 2008). Although the paramount role is for Th1 cells
in protection CD8+ T cells are also generally associated with pro-
tective immunity following primary infection such as in murine
L. major infections (Belkaid et al., 2001, 2002b) or following vac-
cination against L. amazonensis (Colmenares et al., 2003) or L.
donovani (Stager et al., 2003b). Interestingly, BALB/c CD8+T cells
also have an intrinsic defect in the ability to upregulate CXCR3
(Barbi et al., 2008).
While a Th1 response and IFN-γ production and inducible
nitric oxide synthase expression limits L. mexicana infection
in C57BL/6 mice, this is IL-12 independent (Buxbaum et al.,
2002). Nevertheless, immunity in this study was dependent on the
transcription factor Stat-4,which is required for IL-12 signaling. In
this model type-1 interferons have been found not to be the miss-
ing activators of Stat-4 (Buxbaum, 2010). This poses the question
as to whether L. mexicana can directly activate Stat-4 as has been
demonstrated for the virus varicella zoster (Yu et al., 2005). Signif-
icantly, a further study on L. mexicana (Aguilar Torrentera et al.,
2002) demonstrated early but not late resistance to this parasite
in C57BL/6 mice in the absence of IL-12 although the mecha-
nisms involved remain uncharacterized. Alternative mechanisms
of Th1 cell induction independently of IL-12 in other Leishmania
models have been identiﬁed and characterized. Thus, the IL-12
related cytokine IL-27, signaling via WSX-1, has been shown to
counter-regulate the early disease exacerbating effects of IL-4 in
this mouse strain during L. major infection (Artis et al., 2004)
by promoting a Th1 response. IL-27/WSX-1 signaling activates
Stat-1 and T-bet (Takeda et al., 2003) which counter-regulates
GATA 3 expression and Th2 development (Artis et al., 2004). In
the absence of WSX-1 signaling early lesion growth is greatly exac-
erbated although healing under the inﬂuence of IL-12 occurs late
in infection.
Th1 cells are not always associated with healing responses but
have also been associatedwith disease exacerbating conditions and
playing a regulatory role. For example, a study using a virulent L.
major strain that causes non-curing infection in normally resistant
C57BL/6 mice has identiﬁed a CD4+CD25−FoxP3− Th1 popula-
tion (Belkaid et al., 2002a; Anderson et al., 2007) that co-expresses
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IL-10 and IFN-γ and maintains chronic infection. WSX-1 ligation
also activates Stat-3 (Yoshimura et al., 2006) that is a transcription
factor for IL-10. Consequently, this double expressing Th1 sub-
set is diminished in WSX-1−/− mice (Anderson et al., 2009). The
likelihood is that these IFN-γ and IL-10 dual expressing CD4+ T
cells are part of a feed-back regulating process to limit pathology
in late infection and WSX-1−/− mice have increased pathology
following infection though parasite numbers are not increased
(Anderson et al., 2009). CD4+CD25−FoxP3− populations pro-
ducing IL-10, that can be either IFN-γ+ or IFN-γ−, have also
been associated with enhanced disease progression in murine L.
donovani infections (Stager et al., 2006).
Collectively these studies while highlighting the importance of
Th1 responses in protective immunity against Leishmania would
suggest potential elements of redundancy in their induction.How-
ever, they also suggest an element of plasticity in the Th1 cell
population that allows for the induction of a regulatory role in
conditions of prolonged inﬂammation.
T HELPER 2 CELLS: ARE THEY RESPONSIBLE FOR
NON-HEALING DISEASE?
Th2 cells were identiﬁed at the same time as Th1 cells and charac-
terized as producing IL-4, IL-5, IL-9, and IL-13. They were asso-
ciated primarily with immunity to helminths and the pathology
associated with inﬂammatory airways diseases. Initially thought
to be IL-4 dependent in their generation via Stat-6 activation and
GATA 3 induction it is now recognized that GATA 3 is the master
regulator of Th2 differentiation and can be induced independently
of IL-4/IL-13 and Stat-6 activation (Ouyang et al., 1998, 2000;
Brewer et al., 1999; Mohrs et al., 2000).
Early studies in susceptible BALB/c mice demonstrated that
a single T cell epitope derived from the parasite LACK anti-
gen (Leishmania homolog of receptors for activated C kinase)
induced rapid IL-4 production by Vβ4Vα8CD4+ T cells which
apparently rendered T cells unresponsive to IL-12 and correlated
with lesion development (Launois et al., 1995). Thus a partic-
ularly strong case for the predominant role of IL-4 and a Th2
response in non-healing cutaneous disease was established. Nev-
ertheless, other studies on resistant C57BL/6 mice noted that this
strain also produced IL-4 early during infection and yet developed
an unimpaired Th1 biased response (Scott et al., 1996). Subse-
quently studies utilizing IL-4−/− mice seriously questioned the
paramount role of IL-4 in the non-healing response of BALB/c
mice to L. major as a number of apparently contradictory reports
determining the signiﬁcance of IL-4 were published (Kopf et al.,
1996; Noben-Trauth et al., 1996; Mohrs et al., 2000). This posed
the question as to whether other cytokines could be regulating
Th1 development. As IL-4 and IL-13 share a common signaling
pathway through the IL-4 receptor α (IL-4Rα) chain and as IL-4Rα
deﬁcient mice were found to be more resistant than IL-4−/− mice
in one study this suggested a compensatory disease exacerbating
role for IL-13 in the absence of IL-4 (Noben-Trauth et al., 1999).
However, in a further study IL-13 was also found to be able to
act independently of IL-4 and it was concluded that the effects of
IL-4 and IL-13 were also additive (Matthews et al., 2000). Nev-
ertheless, in a further study IL-4Rα−/− BALB/c mice were found
to be more susceptible than IL-4−/− animals indicating a pro-
tective role for IL-13 in preventing disease dissemination in the
absence of IL-4 signaling (Mohrs et al., 1999). While question
marks remain overwhether IL-4 and IL-13 play a signiﬁcant role in
L.major disease progression inBALB/cmice IL-10 unquestionably
does promote parasite persistence in resistant mice and multi-
plication in susceptible mice (Belkaid et al., 2001; Noben-Trauth
et al., 2003). IL-10 could be generated via either Fcγ-mediated
uptake of antibody coated amastigotes (Kane and Mosser, 2001),
or produced by Th2 cells, or CD4+ CD25+ (Belkaid et al., 2001,
2002a; Sacks and Anderson, 2004) or CD4+CD25−FoxP3+ T reg-
ulatory cells (Lages et al., 2008) or indeed CD4+CD25−FoxP3−
Th1 population (Anderson et al., 2007).
In the absence of a deﬁnitive role for IL-4/IL-13 in non-healing
disease it has beenproposed that defectiveT cell responses as a con-
sequence of intrinsic defects in APC function or alternatively in T
cell development could be the ultimate underlying problem deter-
mining the exquisite susceptibility of BALB/c mice to infection
with L. major. While several studies suggest that non-healing dis-
ease is a consequence of the failure to produce or respond to IL-12
(Reiner et al., 1994; Himmelrich et al., 1998) this could be irre-
spective of the presence of a Th2 response and although IL-4 can
down-regulate IL-12 production and expression of IL-12Rβ2 on
CD4+ T cells (Launois et al., 1995; Himmelrich et al., 1998; Jones
et al., 1998), this could also be by IL-4 independent mechanisms
(Jones et al., 2000). In this context it is signiﬁcant that IL-12β2
expression remains impaired in IL-4Rα−/− BALB/c mice com-
pared with resistant C57BL/6 mice infected with L. major (Mohrs
et al., 1999). Defects in APC function reported for BALB/c mice
include a comparative deﬁciency in dendritic cell IL-1 production
(Von Stebut et al., 2003) compared with L. major-resistant strains.
IL-1 has been shown to upregulate dendritic cell IL-12 production
as well as MHC Class II and co-stimulatory molecule expression
(Eriksson et al., 2003) and to enhance IFN-γ mediated inhibition
of Th2 cell proliferation (Oriss et al., 1997). However, as transgenic
IL-12Rβ2 BALB/c mice exhibit a non-healing phenotype despite
intact IL-12 signaling the importance of an APC defect remains in
question (Nishikomori et al., 2001). Irrespective of any potential
defect in APC function, BALB/c CD4+ T cells have been demon-
strated as having an intrinsic IL-4 independent Th2 bias (Baguet
et al., 2004). This may be a consequence of the observed intrinsic
weak co-polarization of the T cell receptor and IFN-γ receptor in
BALB/c naïve T cells compared with C57BL/6 mice (Maldonado
et al., 2004). However, as IL-4 and Stat-6 signaling also sufﬁce to
inhibit this polarization immune-regulatory mechanisms as well
as intrinsic defects could serve to inhibit Th1 responses.
Global gene-deﬁcient mouse models are complex and more
recent studies using cell-type speciﬁc IL-4Rα deﬁcient BALB/c
mouse models may serve to help reconcile the observations above
(Herbert et al., 2004). In contrast to BALB/c mice, which devel-
oped ulcerating lesions following infection with L. major, CD4+ T
cell-speciﬁc IL-4Rα deﬁcient BALB/c mice were resistant and pro-
tected against re-infection in a similar manner to healer C57BL/6
mice (Radwanska et al., 2007). Resistance to L. major in CD4+ T
cell-speciﬁc IL-4Rα−/− mice correlated with reduced numbers of
IL-10-secreting cells and early IL-12p35 mRNA induction, lead-
ing to increased delayed type hypersensitivity responses, IFN-γ
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production, and elevated ratios of inducible nitric oxide synthase
mRNA/parasite numbers, similar to C57BL/6 mice. These data
demonstrated that abrogation of IL-4 signaling in CD4+ T cells is
required to transform non-healer BALB/c mice into a healer phe-
notype.Although global IL-4Rα deﬁcientmice are resistant during
acute infection they are unable to control parasite dissemination
during chronic disease (Mohrs et al., 1999), despite the deletion
of IL-4Rα on T cells. This indicated, that IL-4Rα-responsive cells,
other than CD4+ T cells, played a protective role during L. major
infection in BALB/c mice. Possible candidates include dendritic
cells, as IL-4 treatment of BALB/c mice pre T cell priming has pre-
viously been demonstrated to instruct dendritic cells to produce
IL-12 and facilitate a protectiveTh1 response againstL.major (Bie-
dermann et al., 2001). To investigate this possibility, we recently
generated dendritic cell-speciﬁc IL-4Rα deﬁcient BALB/c mice.
L. major-infected dendritic cell-speciﬁc IL-4Rα−/− mice became
hyper-susceptible, providing evidence that IL-4-instructed DC’s
are beneﬁcial for host protection (manuscript in preparation).
A potential contribution of IL-4/IL-13 responsive non-CD4+cells
toward protective immunitymay explainwhy Leishmania vaccines
incorporating IFN-γ-promoting adjuvants are relatively ineffec-
tive compared with those that also utilize ALUM and subsequently
promote an IL-4 response (Kenney et al., 1999; Gicheru et al.,
2001). By contrast, L. major-infected macrophage/neutrophil spe-
ciﬁc IL-4Rα deﬁcient BALB/c mice showed delayed susceptibil-
ity compared with control mice, despite the presence of type-2
immune responses (Hoelscher et al., 2006). Presumably impaired
alternative macrophage activation with a shift toward classical
macrophage activation resulted in enhanced macrophage nitric
oxidemediated leishmanicidal activity. Promoting alternative acti-
vated macrophage activities by L. major may be an attractive
evasion strategy, allowing elevated parasite growth and hijack-
ing host arginase expression for the pathogens own production of
polyamines.
New world cutaneous leishmaniasis resulting from infection
with parasites of the mexicana complex is under different genetic
and immunoregulatory controls to those controlling L. major
infection and unlike L. major the majority of mouse strains are
susceptible to this parasite. Early studies on L. mexicana complex
parasites that examined IL-4 mRNA transcript expression in the
draining lymph nodes of resistant female and susceptible male
DBA/2 mice indicated that IL-4 played no role in the non-healing
response of male mice to this parasite (Satoskar and Alexander,
1995). Nevertheless, follow up experiments using IL-4−/− mice
to conﬁrm this observation demonstrated that IL-4 was after all
the predominant cytokine responsible for non-healing disease in
a number of other mouse strains (Satoskar et al., 1995, 1997).
However, these apparently contradictory results are now easy to
reconcile as it is now well established that IL-4 transcript expres-
sion is not a reliable indicator of IL-4 production (Mohrs et al.,
2005). IL-4Rα−/− BALB/c mice were found to be more resistant
than IL-4−/− mice to infection with L. mexicana indicating a dis-
ease promoting role for IL-13 (Alexander et al., 2002). This was
conﬁrmed in studies using IL-13−/− mice that indicate that IL-13
may play a role in preventing disease resolution by inhibiting IL-
12Rβ2 expression (Alexander et al., 2002). Inhibiting IL-12Rβ2
would limit Th1 expansion and L. mexicana has indeed been
demonstrated to inhibit Th1 differentiation (Hsu and Scott, 2007).
Unlike global IL-4Ra−/− mice infected with L. mexicana that dis-
play no lesion growth, infected CD4+ T cell speciﬁc IL-4Rα−/−
mice initially developed lesions indicating that early susceptibility
to L. mexicana is dependent on an IL-4 responsive non-CD4+ T
cell population (Bryson et al., 2011). However, subsequent lesion
growth was signiﬁcantly curtailed in infected CD4+ T cell speciﬁc
IL-4Rα−/− mice compared with IL-4Rα intact mice, and a strong
Th1 response generated. This clearly demonstrates the paramount
importance of an expanding Th2 population in progressive L.
mexicana infections. Despite reduced susceptibility in all CD4+
T cell speciﬁc IL-4Rα−/− mice, a dichotomy between the sexes was
identiﬁed during L. mexicana infection and while lesions in female
CD4+ T cell speciﬁc IL-4Rα−/− mice healed they persisted in male
mice associatedwith elevated IL-4production in this sex compared
with females. This would suggest that an IL-4 responsive non-T
cell population is inﬂuencing a non-healing response inmalemice.
In contrast to L. major infection, macrophage/neutrophil signal-
ing via IL-4Rα had minimal effect on the outcome of L. mexicana
infection (Bryson et al., 2011), although this latter study was only
carried out in female mice.
The paramount role of IL-4 in promoting disease progression
is, however, mouse strain and site of infection dependent. Thus
the growth of both L. mexicana and L. amazonensis is primarily
IL-4 dependent in rump infections in BALB/c and C57BL/6 mice
(McMahon-Pratt and Alexander, 2004). By contrast the growth of
these parasites in the footpadof C57BL/6mice, thoughnotBALB/c
mice, is IL-4 independent (Jones et al., 2000; McMahon-Pratt and
Alexander, 2004) and the contribution of IL-10 to this activity may
also depend on whether L. amazonensis or L. mexicana is studied
(Padigel et al., 2003a; Buxbaum and Scott, 2005). Overall there is
no evidence whatsoever that Th2 cytokines can be beneﬁcial dur-
ing infection with New World cutaneous leishmaniasis and often
they play the classic counter-protective role.
Protective immunity against visceral leishmaniasis, as with
species causing cutaneous leishmaniasis, is dependent on an IL-12
driven type-1 response and IFN-γproduction (Murray,1997; Eng-
werda et al., 1998),which results in the induction of parasite killing
by macrophages primarily via the production of reactive nitrogen
andoxygen intermediates (Murray andNathan,1999). Studies,not
only in mice (Kaye et al., 1991), but also humans (Karp et al., 1993;
Kemp et al., 1993; Kemp, 2000), suggested that cure was indepen-
dent of the differential production of Th1 and Th2 cytokines and
both IFN-γ and IL-4 producing T cells have been isolated from
asymptomatic and cured patients. Indeed in the mouse model
it has been shown that the induction of enhanced protection is
related to increasing the frequency of cytokine-producing cells
rather than altering the IFN-γ/IL-4 balance (Murphy et al., 1998).
In addition, while a recent study has shown that the control of
L. donovani in the susceptible BALB/c mouse is IL-12 dependent,
this cytokine was found to promote the expansion of Th2 as well
as Th1 responses (Engwerda et al., 1998). Both human (Kemp
et al., 1993; Murphy et al., 1998) and murine studies (Murphy
et al., 2001) indicate that IL-10 is the major immunosuppres-
sive cytokine in visceral leishmaniasis. Furthermore it has been
demonstrated that the source of this IL-10 is not traditional Th2
cells (Murphy et al., 1998) but more likely a type-1 regulatory T
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cell population (Bodas et al., 2006) as well as non-T cell regulatory
populations.
Thus itwouldprobably be the general consensus of opinion that
the Th2 response does not contribute adversely to the immuno-
logical control of visceral leishmaniasis. Indeed studies utilizing
gene-deﬁcient mice have identiﬁed a protective role for IL-4 and
IL-4Rα signaling during primary L. donovani infections (Satoskar
et al., 1995; Stager et al., 2003a). Furthermore the increased suscep-
tibility of IL-4Rα−/− mice compared with IL-4−/− BALB/c mice
as measured by hepatic parasite burdens (Stager et al., 2003a) also
suggested a protective role for IL-13 as both IL-4 and IL-13 activi-
ties are dependent on the expression of IL-4Rα. Control of parasite
growth in the liver was associated with the ability to produce ster-
ile granulomas (Stager et al., 2003a) a mechanism known to be
driven by T cell derived IFN-γ (Murray et al., 2000). Enhanced
susceptibility of IL-4−/− and IL-4Rα−/− mice was associated with
down-regulated type-1 responses and markedly retarded granu-
loma maturation (Alexander et al., 2000; Stager et al., 2003a,).
Decreased IFN-γ and retarded granuloma maturation have also
been observed in IL-13−/− mice (Murray et al., 2006; McFarlane
et al., 2011); this was associated with an increased parasite burden
(McFarlane et al., 2011). The recent availability of cell-type speciﬁc
IL-4Rα−/− mice has facilitated the dissection of the IL-4 and IL-13
effects during visceral leishmaniasis and so far we have examined
the course of L. donovani in macrophage/neutrophil speciﬁc IL-
4Rα−/− BALB/c mice. The protective activity of IL-4/IL-13 during
visceral leishmaniasis is not via these cell populations (McFar-
lane et al., 2011). Studies using CD4+ T cell speciﬁc IL-4Rα−/−
BALB/c mice demonstrate it is also not via CD4+ or CD8+ T cells
(unpublished).
In addition to playing a signiﬁcant protective role during pri-
mary infection with L. donovani effective sodium stibogluconate
(SSG) chemotherapy is dependent on Th2 cytokines (Alexander
et al., 2000; McFarlane et al., 2011). Previous studies have demon-
strated that successful treatment of visceral leishmaniasis with SSG
requires the presence of both CD4+ and CD8+ T cells (Murray
et al., 1989) accompanied by the type-1 cytokines IL-12 and IFN-γ
(Murray et al., 2000). We have observed that SSG chemotherapy
of L. donovani in IL-4−/− (Alexander et al., 2000) or IL-13−/−
(McFarlane et al., 2011) BALB/c mice compared with wild-type
mice resulted in down-regulated IFN-γ production and increased
IL-10 production. This would suggest a requirement for IL-4 and
IL-13 in instructing a type-1 response. Signiﬁcantly, successful
immunotherapeutic intervention in the BALB/c mouse using a
hybrid cell vaccine which was mediated by a strong CD8+CTL
response was associated with downregulation of IL-10 but sig-
niﬁcantly enhanced IL-4 and IL-13 expression as well as IFN-γ
production (Basu et al., 2007) providing further strong circum-
stantial evidence for these Th2 cytokines facilitating the generation
of type-1 immunity. Similarly the protection afforded by a kineto-
plast membrane protein protein-11 DNA vaccine which protected
hamsters against visceral leishmaniasis correlated with decreased
IL-10 levels but with increased IL-4 production and an elevated
mixed Th1/Th2 response (Basu et al., 2005). However, vaccina-
tion studies utilizing HASPB-1 have provided the most concrete
evidence for a Th2 cytokine requirement to instruct a protective
type-1 response against visceral leishmaniasis (Stager et al., 2003b)
as this vaccine generates a mixed Th1/Th2 response and is totally
ineffective in IL-4 or IL-4Rα−/− mice. The primary source of IL-4
has been deﬁned as a CD11b+CD11clo phagocyte (Stager et al.,
2003b).
T REGULATORY CELLS AND THEIR ROLE IN LEISHMANIASIS
Unlike other CD4+ T cell populations the primary role of T
regulatory cells is homeostasis and limiting excessive inﬂamma-
tion via in particular IL-10 production. T regulatory cells include
FoxP3+CD4+CD25+ natural T regulatory cells (nTregs) that are
thymus derived and inducible Tregs that derive from the periph-
ery and are either FoxP3+ (iTregs) or adaptive FoxP3− type-1 Treg
cells (Tr1; reviewed Peterson, 2012).
The role of Tregs during infection with Leishmania is multi-
faceted and whether their role is disease promoting or protective
depends on the experimentalmodel being investigated. Thus in the
L. major infection model CD4+CD25+ Tregs have been demon-
strated in resistant C57 BL/6 mice to accumulate in the lesions
and draining lymph nodes and be responsible for IL-10 dependent
parasite persistence and latent infection (Belkaid et al., 2001). In
the absence of IL-10 sterile immunity occurs. However, parasite
persistence in apparently healed mice is necessary for concomi-
tant immunity and the maintenance of a viable effector Th1
cell population (Belkaid et al., 2002a). Nevertheless not only can
latent infection provide a reservoir for potential continued para-
site transmission to sandﬂies but persistent parasites can also be a
sourceof disease reactivation. For example FoxP3+ CD25− Tregu-
latory expand inmice and humanswith age and have been demon-
strated to be responsible for spontaneous reactivation of L. major
infections in aged mice (Lages et al., 2008) as they down-regulate
effector Th1 responses. In progressive chronic L. major infection
in normally resistant C57BL/6 mice FoxP3−CD25− type-1 reg-
ulatory cells would appear to play the dominant role (Anderson
et al., 2007). By contrast CD4+CD25+ Treg cells can also play
signiﬁcant disease control roles during L. major infections in sus-
ceptibleBALB/cmiceby regulating thebiasedTh2 response (Aseffa
et al., 2002; Xu et al., 2003). In the absence of CD4+CD25+ Treg
cells IL-4 levels were increased and L. major infection was exac-
erbated (Aseffa et al., 2002). In addition non-healing disease, in
CD4+CD25− T cell reconstituted SCID mice, was controlled by
addition of CD4+CD25+ regulatory T cells (Aseffa et al., 2002; Xu
et al., 2003). Nevertheless impairing the expansion and homing
of FoxP3+CD4+CD25+ T cells to sites of infection by inacti-
vating the p110δ isoform of phosphatidylinositol 3 kinase results
in increased resistance in both L. major-resistant and susceptible
mice (Liu et al., 2009). This implies the potential for therapeutic
intervention with pharmacological inhibitors of this enzyme.
In non-healing L. amazonensis infections of C57BL/6 mice
CD4+CD25+ regulatory T cell populations can adoptively trans-
fer a degree of resistance to naïve recipients while RAG−/− mice
reconstituted with spleen cells depleted of this population have
higher parasite burdens and more pathology than those reconsti-
tuted with intact spleen cells (Ji et al., 2005). This study indicated a
role for nTregs in inducing IFN-γ producing effector cells. In con-
trast in studies using the related parasite L. mexicana depletion of
CD4+CD25+ T cells did not alter the course of infection (Thomas
and Buxbaum, 2008).
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While CD4+CD25+T cells have been found in L. braziliensis
lesions in humans no functional role has been ascribed to them
(Campanelli et al., 2006). By contrast a series of elegant studies
have highlighted a signiﬁcant role for Tregs in humans infected
with L. guyanensis (Bourreau et al., 2001, 2009). CD4+CD25+
T regulatory cells are found in lesions during early acute as
well as chronic infection. While Tregs from both acute and
chronic patients inhibited IFN-γ production from CD4+CD25−
T cells exposed to parasite antigen, intralesional FoxP3, and IL-10
expression is particularly elevated in those patients with chronic
disease.
It iswell established that IL-10 is themajor inﬂuence resulting in
non-healing visceral leishmaniasis. However, little role for nTregs
has been noted in either human (Nylén et al., 2007) or murine
L. donovani infection (Stager et al., 2006). Any disease exacerba-
tory role for CD4+ Tregs has been attributed to FoxP3−CD25−
regulatory (type-1) cells. These may also produce IFN-γ as well
as IL-10 suggesting a further stage of Th1 development. Indeed
numerous non-T cell populations, including DCs (Svensson et al.,
2004) and NK cells (Maroof et al., 2008) have been implicated as
playing regulatory roles during visceral leishmaniasis. As with Th1
cells producing IL-10 these non-traditional regulatory populations
may come about as a homeostatic mechanism to counteract the
effects of prolonged inﬂammation. However, a recent study has
suggested a strong correlation between the parasite burdens in
post kala-azar dermal leishmaniasis nodules and FoxP3 and IL-10
levels (Katara et al., 2011).
T HELPER 17 CELLS AND THEIR ROLE IN LEISHMANIASIS
T helper 17 cells are primarily associated with protecting mucosal
surfaces, but also with excessive pathology, autoimmune diseases,
and allergies (reviewed Korn et al., 2009). Their development is
committed under the inﬂuence of TGF-β and IL-6 and or IL-21
with the retinoic-acid orphan related receptors (ROR-α and ROR-
γt) being critical transcription factors in differentiation. Th17 cells
are characterized in particular by IL-17 production, and also by
IL-22 and IL-21 secretion. IL-17 plays a signiﬁcant role in the
migration, recruitment, and activation of neutrophils. As neu-
trophils have been demonstrated to have the potential to play
important effector and or regulatory functions during Leishma-
nia infections it would be expected that Th17 cells would have
signiﬁcant roles to play during Leishmania infection (reviewed
Charmoy et al., 2010). For example while neutrophils contribute
to a protective response against L. donovani they promote a non-
healing response against L. major in BALB/c mice. Overall the role
of Th17 cells in leishmaniasis remains unclear and both disease
promoting and protective responses have been attributed to their
inﬂuence. Undoubtedly, the infecting species as well as the genetic
background of the host play a role in Th17 cell activities.
With regard to the “mexicana” complex of parasites there is
little by way of published evidence to indicate a role. However,
the inadequate immune response against L. amazonensis resulting
in chronic infection in mice has been associated with the induc-
tion of “pathogenic” CD4+ T cells producing high levels of IL-17
(Xin et al., 2007). A disease exacerbating role for IL-17 following
L. major infection has also been observed in studies using IL-
17 deﬁcient BALB/c mice which developed smaller lesions with
fewer parasites than their wild-type counterparts (Lopez Kostka
et al., 2009). While T cell IL-4, IL-10, and IFN-γ production
were comparable in IL-17−/− and IL-17+/+ mice, CXCL2 expres-
sion, and neutrophil recruitment were signiﬁcantly reduced in the
absence of IL-17.
Th17 cell development, and IL-17 production are down-
regulated by IL-27/WSX-1 signaling (Fitzgerald et al., 2007). Prior
to the characterization of Th17 cells increased L. major growth in
IL-27R−/− (WSX-1−/−) C57 BL/6 mice in the healing C57BL/6
model was attributed to a diminished Th1 response (Artis et al.,
2004). Subsequently it has been shown that IL-27R−/− (WSX-
1−/−) C57 BL/6 mice infected with a virulent strain of L. major,
that induced non-healing disease in these normally resistant mice,
had enhanced Th17 development and increased pathology though
no difference in parasite numbers compared with wild-type con-
trols (Anderson et al., 2009). However, as the IL-27/WSX-1 sig-
naling pathway has also been associated with promoting Th1 cell
development by inhibiting IL-4 production (Artis et al., 2004) and
also in enhancing IL-10 production from CD4+ T cells (Anderson
et al., 2009) this can often make interpretation of effects utilizing
IL-27R−/− (WSX−/−) mice difﬁcult.
While the evidence might suggest a counter-protective role for
IL-17 in Old and New world cutaneous leishmaniasis a recent
study using aCpGadjuvanted live vaccine protectedC57BL/6mice
againstL.major associatedwith the speciﬁc inductionof Th17 cells
(Wu et al., 2010). Similarly a vaccine comprising CpG stimulated
bone marrow-derived DCs pulsed with L. infantum KMP-11 pep-
tide induced protection in BALB/c mice against visceral infection
associated with overproduction of IL-17 (Agallou et al., 2011). It
should be noted that vaccination in both studies also enhanced
type-1 responses. However, studies in humans do indeed demon-
strate a therapeutic role for Th17 cells as IL-17 and IL-22 have been
strongly correlated with protection against visceral leishmaniasis
(Pitta et al., 2009). Furthermore studies in IL-27R−/− (WSX-
1−/−) C57 BL/6 mice demonstrated them to be signiﬁcantly more
resistant than their wild-type counterparts to infection with L.
donovani although this resistance was associated with severe liver
pathology (Rosas et al., 2006). While pro-inﬂammatory cytokine
production was signiﬁcantly up-regulated in IL-27R−/− mice and
IL-10 levels down-regulated during chronic disease unfortunately
the IL-17 component was not studied at that time.
Finally the uncertainty surrounding the role of IL-17 is empha-
sized in studies involving the L. (viannia) sub-genus. Healing in
a murine model of L. braziliensis infection (Vargas-Inchaustegui
et al., 2008) as well as resolution of L. panamensis infections in
IL-13−/− mice (Castilho et al., 2010) is associated with elevated
IL-17 as well as IFN-γ levels. Similarly elevated levels of IL-17
were identiﬁed in sub-clinical L. braziliensis human infections
(Novoa et al., 2011) although a signiﬁcant role for IL-17 mediated
neutrophil inﬁltration has been associated with tissue damage in
human mucosal leishmaniasis (Boaventura et al., 2010).
T HELPER 9 CELLS AND THEIR ROLE IN LEISHMANIASIS
Th9 cells are often considered a subset of Th2 cells, generated by
IL-4, but requiring the additional inﬂuence of TGF-β to be repro-
grammed, as well as IL-2 (reviewed Jäeger and Kuchroo, 2010;
Nowak and Noelle, 2010). Conversely, expansion of the Th9 cell
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population is inhibited by IFN-γ. Th9 cells express the transcrip-
tion factor PU.1 but do not express T-bet, GATA 3, ROR-γt, or
Foxp3. Th9 cells produce both IL-9 and IL-10 although IL-10
expression is not regulated by PU.1.While Th9 cells are considered
themain source of IL-9, this cytokine can also beproducedbyTh17
and Treg cells. Th9 cells and IL-9 production have been associated
with Mast cell recruitment and expansion, the pathology asso-
ciated with atopic allergy and immunity to nematode infection
(Faulkner et al., 1998).
Studies examining the role of IL-9 during leishmaniasis are
limited and have only involved L. major. Early studies demon-
strated that IL-9 could be induced early during infection in both
susceptible BALB/c and resistant DBA/2 and C57BL/6 mice (Gess-
ner et al., 1993; Nashed et al., 2000). However, higher levels of
IL-9 were observed in susceptible BALB/c mice and the ability
of CD4 T cells to produce IL-9 persisted only in BALB/c mice
as infection progressed. The disease promoting activity of IL-9
indicated circumstantially by these early studies was conﬁrmed
in BALB/c mice rendered deﬁcient in IL-9 by vaccination with
a recombinant IL-9/Freunds Adjuvant complex (Arendse et al.,
2005). Following IL-9 depletion BALB/c mice become more resis-
tant to L. major infection and there was a switch in the Th2/Th1
balance in favor of a protective type-1 response. This resulted in a
switch from a classically to an alternatively activated macrophage
phenotype as characterized by increased microbicidal activity
associated with higher NO production and reduced arginase-1
expression.
FOLLICULAR HELPER CD4+ T CELLS AND THEIR POTENTIAL
ROLE IN LEISHMANIASIS
Follicular helper (CD4+ T cells) have been recognized as the spe-
cialized providers of B cell help (reviewed Crotty, 2011). Although
they have been identiﬁed as themajor producers of IL-4 and IFN-γ
in the draining lymph nodes during parasite infection (Reinhardt
et al., 2009), they are distinct from Th1 and Th2 cells. They are
dependent on expression of the master regulator Bcl6 and the
absence of Blimp1, which is expressed by other CD4 T cell sub-
populations and counter-regulated by Bcl6. Tfh cells are further
characterized by the expression of CXCR5, PD-1, IL-21, and iCOS.
They play a major role in lymph node germinal center formation
and are critical in the differentiation of B cells into plasma cells
and high afﬁnity antibody production. During L. major infection
in BALB/c mice Tfh cells and not canonical Th2 cells provided
virtually all the IL-4 secreting cells in the draining lymph nodes
(Reinhardt et al., 2009). While DCs may be the initial APCs for
Tfh cells as they develop from naïve precursors in the T cell zone
of lymph nodes activated B cells take over this role at the T cell-B
cell zone border (Deenick et al., 2011). Consequently if B cells and
or speciﬁc antibody production play a signiﬁcant role in the dis-
ease process Tfh cells would comprise a signiﬁcant population in
determining disease outcome.
The role of B cells (as APCs or regulatory cells) and/or antibody
in contributing to susceptibility to Leishmania infection appears
to depend in large part upon the parasite species examined but
also probably to a signiﬁcant extent upon the host.
Evidence for a role of B cells and/or antibody in the suscepti-
bility to infection with L. major has been variable which may be
a result of the particular parasite or mouse strain used (Varkila
et al., 1993; Brown and Reiner, 1999). In one study using T cell-
reconstituted L. major-resistant C.B-17 SCID mice, B cells were
shown to convert resistance into susceptibility. However, other
studies have not found B cells to affect the course of infection
in T cell reconstituted mice (Varkila et al., 1993). Further, studies
employing B cell deﬁcient mice (BALB/c or C57BL/6) and infec-
tion with L. major promastigotes or amastigotes have indicated
that neither antibodies nor B cells are required for susceptibility
to L. major infection (Brown and Reiner, 1999; Colmenares et al.,
2002). Nevertheless a further study has shown FcγR−/− BALB/c
mice to be resistant to L. major and this resistance was associated
with decreased IL-10 production (Padigel and Farrell, 2005). The
inference was that FcγR mediated uptake of opsonized parasites
and associated IL-10 production mediated non-healing disease in
wild-type mice (Kane and Mosser, 2001). However, these appar-
ently contradictory results may now have been reconciled at least
in part. Thus Ronet et al. (2008) have demonstrated that while
B cell deﬁcient BALB/c mice are more resistant than their wild-
type counterparts to infection with the LV39 strain of L. major
these mice remained susceptible to two other strains of this par-
asite. This B cell dependent susceptibility to the LV39 strain of L.
major was independent of antibodies and attributed to B cell anti-
gen presentation. A further study determined that regulatory B
cells instructed a Th2 response via IL-10 production (Ronet et al.,
2010). The lack of evidence for a role for antibody in susceptibility
to L. major infection is still somewhat surprising given some of the
previous observations (e.g., Padigel and Farrell, 2005). However,
it may be that other immunological down-regulatory mecha-
nisms (IL-4 and IL-13) may compensate or that the other mecha-
nisms that induce an IL-10 response are more signiﬁcant globally.
Recently, B cell-speciﬁc IL-4Rα deﬁcient BALB/c mice were estab-
lished (Hoving et al., 2012). As a consequence of impaired IL-4Rα
responsiveness, ovalbumin immunization resulted in abrogated B
cell-type-2 antibody responses (IgG1 and IgE) with similar low
levels as found in global IL-4Rα deﬁcient mice. In contrast, type-
1-antibody responses were up-regulated, as shown by elevated
ovalbumin-speciﬁc IgG2a and IgG2b. L. major infection studies
have been initiated and should more deﬁnitively deﬁne a possi-
ble role of IL-4Rα responsive B cells in this experimental model
system.
Infection of B cell deﬁcient mice by any species of the L. mex-
icana complex has been found to be associated with resistance
and susceptibility to infection could be passively transferred with
antibody but not by B cells trans-genetically reconstituted and
capable of antigen presentation (Peters et al., 1995; Kima et al.,
2000; Colmenares et al., 2002). The immune responses of CD4+
T cells from the draining lymph nodes of infected B cell deﬁ-
cient and wild-type BALB/c mice were comparable, both in terms
of the level of proliferation and the cytokines produced (IL-4,
IL-10, IFN-γ). Hence, T cell activation was comparable in both
groups of mice and a lack of a T cell response in the B cell
deﬁcient mice did not contribute to the diminished pathology.
What differed signiﬁcantly were the responses at the cutaneous
site of infection. B cell deﬁcient animals had markedly reduced
numbers of monocytes and lymphocytes recruited or retained at
the site of cutaneous infection in comparison to wild-type mice,
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indicating a selective impairment in the local cutaneous immune
response. Consistent with this observation and a role for antibody
in pathogenesis, FcγR-deﬁcientmicewere also relatively refractory
to infection (Kima et al., 2000; Buxbaum and Scott, 2005; Thomas
and Buxbaum, 2008). C57BL/6 deﬁcient in FcγR or FcγRIII unlike
their wild-type counterparts healed following L. mexicana infec-
tion and developed a Th1 response while IL-10 levels were reduced
in the site of infection in FcγRIII−/− mice (Buxbaum and Scott,
2005;Thomas andBuxbaum,2008). IL-10 levels in draining lymph
nodes were similar from both wild-type and FcγRIII−/− mice and
depletion of Treg cells, the main producers of IL-10 in the drain-
ing lymph nodes of wild-type mice, did not modify the immune
response or disease outcome. In vitro IgG1 and IgG2a/c can both
induce similar levels of IL-10 production from macrophages. IgG1
deﬁcient mice have increased resistance against L. mexicana but
at the same time have increased IgG2a/c levels. However, while
IgG1 induces IL-10 entirely via FcγRIII, IgG2a/c utilizes primar-
ily FcγR1 but also to a lesser degree FcγRIII (Chu et al., 2010).
Overall this indicates that a crucial cell for FcγRIII engagement
is present in the lesion site to maintain non-healing disease and
consequently thatTfh cells excreting IL-4 to induceB cell IgG1pro-
duction are likely playing a signiﬁcant role in pathology. However,
although we have found that B cell speciﬁc IL-4Rα−/− mice on the
BALB/c background did not produce parasite speciﬁc IgG1, they
remained susceptible to L.mexicana infection (unpublished). Fur-
ther investigations are currently in progress to better understand
this apparent paradox.
In the case of visceral leishmaniasis, both C57BL/6 infected
with L. donovani (Smelt et al., 2000) and BALB/c infected with
L. infantum (Deak et al., 2010), B cell deﬁcient mice are rela-
tively resistant to infection. However, susceptibility as measured
by parasite growth in B cell deﬁcient C57BL/6 mice, unlike
BALB/c mice is independent of antibody production, although
antibodies do protect C57BL/6 mice from exaggerated pathol-
ogy during infection. In BALB/c mice infected with L. infan-
tum neither B cell IL-10 production or antigen presentation
played a signiﬁcant role in B cell mediated disease exacer-
bation. Passive transfer experiments indicated that antibodies,
IgM and IgG, induced as a result of parasite induced poly-
clonal B cell activation promoted parasite growth. While Tfh
cells have been reported as triggering hypergammaglobulinemia
during chronic Salmonella infection (Ko et al., 2011) whether
they can do this early in visceral leishmaniasis remains to be
determined.
CONCLUSION
It has been some quarter of a century since two distinct CD4+ T
cell populations, T helper 1 and 2,were identiﬁed by their different
cytokine proﬁles. This seminal discovery provided a basic frame-
work around which immunologists could test their various “pet”
hypotheses with regard to how immune-regulatory mechanisms
controlled infectious diseases on the one hand while on the other
hand limiting immune-pathological processes. Early observa-
tions, particularly on the murine cutaneous leishmaniasis model,
demonstrated that Th1 and Th2 responses via their signatory
cytokines, IFNγ, and IL-4 respectively, were counter-regulatory.
However, later studies using gene-deﬁcient mice have questioned
the precise role of the Th2 response and IL-4 in regulating the Th1
response. Depending on the parasite strain/species/host model
studied the Th2 response could either promote infection or at
best be irrelevant to disease progression. Furthermore depending
on the model IL-4/IL-13 could actually promote a Th1 response
as happens in visceral leishmaniasis. Our current studies using
cell-type speciﬁc IL-4Rα−/− have been making huge inroads into
dissecting out and understanding these apparent paradoxes.
Given that bothTh1 andTh2 responses are inﬂammatory, albeit
distinct, responses evolved respectively against intracellular par-
asites and large pathogens, it now seems obvious in retrospect
that other distinct regulatory CD4+ T cell populations would
operate to control excessive inﬂammatory processes induced by
either population. Subsequently new CD4+ T cell populations,
both regulatory and inﬂammatory, and inﬂuencing the outcome
of Leishmania infections have been characterized as summarized
in the above review. Furthermore the degree of plasticity amongst
T cell populations is much greater than previously thought such
that type-1 CD4+ T cells can also be regulatory and express IL-10.
In the ideal scenario following infection with Leishmania infec-
tion Th1 responses are induced sufﬁcient to control infection
initially while regulatory mechanisms are necessary laterly to pre-
vent excessive pathology,maintain a latent (sub-clinical) infection
and immunity to re-infection. Perturbation of this balance results
in either progressive or chronic disease.
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